Skip to main content
SpringerLink
Log in

The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research

  • Chapter
  • First Online:
Substance Use Disorders

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 258))

Abstract

Substance use disorders represent a global public health issue. This mental health disorder is hypothesized to result from neurobiological changes as a result of chronic drug exposure and clinically manifests as inappropriate behavioral allocation toward the procurement and use of the abused substance and away from other behaviors maintained by more adaptive nondrug reinforcers (e.g., social relationships, work). The dynorphin/kappa-opioid receptor (KOR) is one receptor system that has been altered following chronic exposure to drugs of abuse (e.g., cocaine, opioids, alcohol) in both laboratory animals and humans, implicating the dynorphin/KOR system in the expression, mechanisms, and treatment of substance use disorders. KOR antagonists have reduced drug self-administration in laboratory animals under certain experimental conditions, but not others. Recently, several human laboratory and clinical trials have evaluated the effectiveness of KOR antagonists as candidate pharmacotherapies for cocaine or tobacco use disorder to test hypotheses generated from preclinical studies. KOR antagonists failed to significantly alter drug use metrics in humans suggesting translational discordance between some preclinical drug self-administration studies and consistent with other preclinical drug self-administration studies that provide concurrent access to an alternative nondrug reinforcer (e.g., food). The implications of this translational discordance and future directions for examining the therapeutic potential of KOR agonists or antagonists as candidate substance use disorder pharmacotherapies are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ator NA, Griffiths RR (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 70:S55–S72

    Article  CAS  PubMed  Google Scholar 

  • Banks ML, Negus SS (2012) Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Adv Pharmacol Sci 2012:281768

    PubMed  PubMed Central  Google Scholar 

  • Banks ML, Negus SS (2017) Insights from preclinical choice models on treating drug addiction. Trends Pharmacol Sci 38:181–194

    Article  CAS  PubMed  Google Scholar 

  • Banks ML, Hutsell BA, Schwienteck KL, Negus SS (2015) Use of preclinical drug vs. food choice procedures to evaluate candidate medications for cocaine addiction. Curr Treat Options Psychiatry 2:136–150

    Article  PubMed  PubMed Central  Google Scholar 

  • Banks ML, Townsend EA, Negus SS (2019) Testing the 10 most wanted: a preclinical algorithm to screen candidate opioid use disorder medications. Neuropsychopharmacology

    Google Scholar 

  • Bowen CA, Negus SS, Zong R, Neumeyer JL, Bidlack JM, Mello NK (2003) Effects of mixed-action κ/μ opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Neuropsychopharmacology 28:1125–1139

    Article  CAS  PubMed  Google Scholar 

  • Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH (1993) Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267:1269–1276

    CAS  PubMed  Google Scholar 

  • Butelman ER, Ko M-C, Sobczyk-Kojiro K, Mosberg HI, Van Bemmel B, Zernig G, Woods JH (1998) Kappa-opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. J Pharmacol Exp Ther 285:595–601

    CAS  PubMed  Google Scholar 

  • Carlezon WA, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY-W, Cohen BM (2006) Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440–447

    Article  CAS  PubMed  Google Scholar 

  • Carter LP, Griffiths RR (2009) Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend 105(Suppl 1):S14–S25

    Article  CAS  PubMed  Google Scholar 

  • Cashman JR, Azar MR (2014) Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonist. J Pharmacol Exp Ther 350:171–180

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chavkin C, Koob GF (2015) Dynorphin, dysphoria, and dependence: the stress of addiction. Neuropsychopharmacology 41:373

    Article  PubMed Central  CAS  Google Scholar 

  • Chavkin C, James I, Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215:413–415

    Article  CAS  PubMed  Google Scholar 

  • Clarke T-K, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O’Brien CP, Oslin DW, Lohoff FW (2012) Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes Brain Behav 11:415–423

    Article  CAS  PubMed  Google Scholar 

  • Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL (2008) The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96:1–15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cosgrove KP, Carroll ME (2002) Effects of bremazocine on self-administration of smoked cocaine base and orally delivered ethanol, phencyclidine, saccharin, and food in rhesus monkeys: a behavioral economic analysis. J Pharmacol Exp Ther 301:993–1002

    Article  CAS  PubMed  Google Scholar 

  • Crowley NA, Kash TL (2015) Kappa opioid receptor signaling in the brain: circuitry and implications for treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 62:51–60

    Article  CAS  Google Scholar 

  • Czoty PW, Stoops WW, Rush CR (2016) Evaluation of the “Pipeline” for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research. Pharmacol Rev 68:533–562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Daunais JB, Roberts DC, McGinty JF (1993) Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport 4:543–546

    Article  CAS  PubMed  Google Scholar 

  • Deehan GA, McKinzie DL, Carroll FI, McBride WJ, Rodd ZA (2012) The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats. Pharmacol Biochem Behav 101:581–587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Devine DP, Leone P, Pocock D, Wise RA (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266:1236–1246

    CAS  PubMed  Google Scholar 

  • Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274–5278

    Article  PubMed  PubMed Central  Google Scholar 

  • Domi E, Barbier E, Augier E, Augier G, Gehlert D, Barchiesi R, Thorsell A, Holm L, Heilig M (2018) Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders. Neuropsychopharmacology 43:1805–1812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF (1992) Kappa agonist-induced reduction in dopamine release: site of action and tolerance. Res Commun Chem Pathol Pharmacol 78:193–210

    CAS  PubMed  Google Scholar 

  • Doyon WM, Howard EC, Shippenberg TS, Gonzales RA (2006) κ-Opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology 51:487–496

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fagergren P, Smith HR, Daunais JB, Nader MA, Porrino LJ, Hurd YL (2003) Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration. Eur J Neurosci 17:2212–2218

    Article  CAS  PubMed  Google Scholar 

  • Ferster C, Skinner B (1957) Schedules of reinforcement. Appleton-Century-Croft, New York

    Book  Google Scholar 

  • Freeman KB, Naylor JE, Prisinzano TE, Woolverton WL (2014) Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys. Psychopharmacology 231:2751–2758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Glick SD, Maisonneuve IM, Raucci J, Sydney A (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147–152

    Article  CAS  PubMed  Google Scholar 

  • Glick SD, Visker KE, Maisonneuve IM (1998) Effects of cyclazocine on cocaine self-administration in rats. Eur J Pharmacol 357:9–14

    Article  CAS  PubMed  Google Scholar 

  • Haney M, Spealman R (2008a) Controversies in translational research: drug self-administration. Psychopharmacology 199:403–419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haney M, Spealman R (2008b) Controversies in translational research: drug self-administration. Psychopharmacology 199:403–419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Helal MA, Habib ES, Chittiboyina AG (2017) Selective kappa opioid antagonists for treatment of addiction, are we there yet? Eur J Med Chem 141:632–647

    Article  CAS  PubMed  Google Scholar 

  • Hoffmeister F (1979) Progressive-ratio performance in the rhesus monkey maintained by opiate infusions. Psychopharmacology 62:181–186

    Article  CAS  PubMed  Google Scholar 

  • Hölter SM, Henniger MSH, Lipkowski AW, Spanagel R (2000) Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology 153:93–102

    Article  PubMed  Google Scholar 

  • Hunter JC, Leighton GE, Meecham KG, Boyle SJ, Horwell DC, Rees DC, Hughes J (1990) CI-977, a novel and selective agonist for the κ-opioid receptor. Br J Pharmacol 101:183–189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hurd YL, Herkenham M (1993) Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13:357–369

    Article  CAS  PubMed  Google Scholar 

  • Hutsell BA, Cheng K, Rice KC, Negus SS, Banks ML (2016) Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addict Biol 00:360–373

    Article  CAS  Google Scholar 

  • Ismayilova N, Shoaib M (2010) Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats. Psychopharmacology 210:211–220

    Article  CAS  PubMed  Google Scholar 

  • Jones JD, Babalonis S, Marcus R, Vince B, Kelsh D, Lofwall MR, Fraser H, Paterson B, Martinez S, Martinez DM, Nunes EV, Walsh SL, Comer SD (2019) A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior. Addict Biol 0: e12799

    Google Scholar 

  • Koob GF, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatr 164:1149–1159

    Article  PubMed  Google Scholar 

  • Koob GF, Mason BJ (2016) Existing and future drugs for the treatment of the dark side of addiction. Ann Rev Pharmacol Toxicol 56:299–322

    Article  CAS  Google Scholar 

  • Koob GF, Moal ML (2008) Addiction and the brain antireward system. Annu Rev Psychol 59:29–53

    Article  PubMed  Google Scholar 

  • Koob GF, Volkow ND (2009) Neurocircuitry of addiction. Neuropsychopharmacology 35:217

    Article  PubMed Central  Google Scholar 

  • Kuzmin AV, Semenova S, Gerrits MAFM, Zvartau EE, Van Ree JM (1997) κ-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur J Pharmacol 321:265–271

    Article  CAS  PubMed  Google Scholar 

  • Kuzmin AV, Gerrits MA, Van Ree JM (1998) Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats. Eur J Pharmacol 358:197–202

    Article  CAS  PubMed  Google Scholar 

  • Leitl MD, Onvani S, Bowers MS, Cheng K, Rice KC, Carlezon WA Jr, Banks ML, Negus SS (2014) Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous kappa-opioids. Neuropsychopharmacology 39:614–624

    Article  CAS  PubMed  Google Scholar 

  • Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J (2016) Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the cocaine use reduction with buprenorphine (CURB) study. Addiction 111:1416–1427

    Article  PubMed  PubMed Central  Google Scholar 

  • Liu X, Jernigan C (2011) Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration. Prog Neuro-Psychopharmacol Biol Psychiatry 35:146–153

    Article  CAS  Google Scholar 

  • Marinelli M, Barrot M, Simon H, Oberlander C, Dekeyne A, Moal ML, Piazza PV (1998) Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. Eur J Neurosci 10:3269–3275

    Article  CAS  PubMed  Google Scholar 

  • Martinez D, Slifstein M, Matuskey D, Nabulsi N, Zheng M-Q, Lin S-f, Ropchan J, Urban N, Grassetti A, Chang D, Salling M, Foltin R, Carson RE, Huang Y (2019) Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study. Neuropsychopharmacology

    Google Scholar 

  • Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375–424

    Article  CAS  PubMed  Google Scholar 

  • Mello NK, Negus SS (1998) Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther 286:812–824

    CAS  PubMed  Google Scholar 

  • Mitchell JM, Liang MT, Fields HL (2005) A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology 182:384–392

    Article  CAS  PubMed  Google Scholar 

  • Morales M, Anderson RI, Spear LP, El V (2014) Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on ethanol intake: impact of age and sex. Dev Psychobiol 56:700–712

    Article  CAS  PubMed  Google Scholar 

  • Munro TA, Huang X-P, Inglese C, Perrone MG, Van't Veer A, Carroll FI, Béguin C, Carlezon WA Jr, Colabufo NA, Cohen BM, Roth BL (2013) Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters. PLoS One 8:e70701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nagase H, Imaide S, Hirayama S, Nemoto T, Fujii H (2012) Essential structure of opioid κ receptor agonist nalfurafine for binding to the κ receptor 2: synthesis of decahydro(iminoethano)phenanthrene derivatives and their pharmacologies. Bioorg Med Chem Letts 22:5071–5074

    Article  CAS  Google Scholar 

  • Negus SS (2004) Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology 176:204–213

    Article  PubMed  CAS  Google Scholar 

  • Negus SS, Banks ML (2018) Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: implications for negative reinforcement as a driver of addiction and target for medications development. Pharmacol Biochem Behav 164:32–39

    Article  CAS  Google Scholar 

  • Negus SS, Rice KC (2009) Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys. Neuropsychopharmacology 34:899–911

    Article  CAS  PubMed  Google Scholar 

  • Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, Koob GF (1993) Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 265:1245–1252

    CAS  PubMed  Google Scholar 

  • Negus SS, Mello NK, Portoghese PS, Lin C-E (1997) Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 282:44–55

    CAS  PubMed  Google Scholar 

  • Negus SS, Schrode K, Stevenson GW (2008) Mu/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability. Exp Clin Psychopharmacol 16:386–399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nestby P, Schoffelmeer ANM, Homberg JR, Wardeh G, De Vries TJ, Mulder AH, Vanderschuren LJMJ (1999) Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference. Psychopharmacology 142:309–317

    Article  CAS  PubMed  Google Scholar 

  • Oka T, Negishi K, Suda M, Sawa A, Fujino M, Wakimasu M (1982) Evidence that dynorphin-(1–13) acts as an agonist on opioid κ-receptors. Eur J Pharmacol 77:137–141

    Article  CAS  PubMed  Google Scholar 

  • Pfeiffer A, Brantl V, Herz A, Emrich H (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774–776

    Article  CAS  PubMed  Google Scholar 

  • Rasmussen K, White DA, Acri JB (2019) NIDA’s medication development priorities in response to the opioid crisis: ten most wanted. Neuropsychopharmacology 44:657–659

    Article  PubMed  Google Scholar 

  • Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (1994) Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330–334

    CAS  PubMed  Google Scholar 

  • Reed B, Butelman ER, Fry RS, Kimani R, Kreek MJ (2017) Repeated administration of opra kappa (LY2456302), a novel, short-acting, selective KOP-r antagonist, in persons with and without cocaine dependence. Neuropsychopharmacology 43:739

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, Shaw DB, Sahr AE, Adams BL, Quimby SJ, Diaz N, Jimenez A, Pedregal C, Mitch CH, Knopp KL, Anderson WH, Cramer JW, McKinzie DL (2014) LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Neuropharmacology 77:131–144

    Article  CAS  PubMed  Google Scholar 

  • Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous κ opioid selective agonist. Proc Natl Acad Sci U S A 99:11934–11939

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schank JR, Goldstein AL, Rowe KE, King CE, Marusich JA, Wiley JL, Carroll FI, Thorsell A, Heilig M (2012) The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety. Addict Biol 17:634–647

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology 144:339–346

    Article  CAS  PubMed  Google Scholar 

  • Schenk S, Partridge B, Shippenberg TS (2001) Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration. Neuropsychopharmacology 24:441

    Article  CAS  PubMed  Google Scholar 

  • Schlosburg JE, Whitfield TW, Park PE, Crawford EF, George O, Vendruscolo LF, Koob GF (2013) Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake. J Neurosci 33:19384–19392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schmid CL, Streicher JM, Groer CE, Munro TA, Zhou L, Bohn LM (2013) Functional selectivity of 6′-guanidinonaltrindole (6′-GNTI) at κ-opioid receptors in striatal neurons. J Biol Chem 288:22387–22398

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shippenberg TS, Zapata A, Chefer VI (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116:306–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Skinner B (1938) The behavior of organisms. Appleton-Century-Crofts, New York

    Google Scholar 

  • Solecki W, Ziolkowska B, Krowka T, Gieryk A, Filip M, Przewlocki R (2009) Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration. Brain Res 1255:113–121

    Article  CAS  PubMed  Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734–1740

    Article  CAS  PubMed  Google Scholar 

  • Staley JK, Rothman RB, Rice KC, Partilla J, Mash DC (1997) κ2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. J Neurosci 17:8225–8233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang AH, Collins RJ (1985) Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys. Psychopharmacology 85:309–314

    Article  CAS  PubMed  Google Scholar 

  • Tejeda HA, Bonci A (2019) Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders. Brain Res 1713:91–101

    Article  CAS  PubMed  Google Scholar 

  • Townsend EA, Naylor JE, Negus SS, Edwards SR, Qureshi HN, McLendon HW, McCurdy CR, Kapanda CN, do Carmo JM, da Silva FS, Hall JE, Sufka KJ, Freeman KB (2017) Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats. Psychopharmacology 234:2597–2605

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Walker BM, Zorrilla EP, Koob GF (2011) Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol 16:116–119

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE (2001) Enadoline and butorphanol: evaluation of κ-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 299:147–158

    CAS  PubMed  Google Scholar 

  • Wee S, Koob G (2010a) The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210:121–135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wee S, Koob GF (2010b) The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology 210:121–135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wee S, Orio L, Ghirmai S, Cashman J, Koob G (2009) Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology 205:565–575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wee S, Vendruscolo LF, Misra KK, Schlosburg JE, Koob GF (2012) A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence. Science Transl Med 4:146ra110

    Article  CAS  Google Scholar 

  • Whitfield TW, Schlosburg JE, Wee S, Gould A, George O, Grant Y, Zamora-Martinez ER, Edwards S, Crawford E, Vendruscolo LF, Koob GF (2015) κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake. J Neurosci 35:4296–4305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Woods JH, Gmerek DE (1985) Substitution and primary dependence studies in animals. Drug Alcohol Depend 14:233–247

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA

    Matthew L. Banks

Authors
  1. Matthew L. Banks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew L. Banks .

Editor information

Editors and Affiliations

  1. Wake Forest School of Medicine, Winston-Salem, NC, USA

    Michael A. Nader

  2. Addiction Institute of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Yasmin L. Hurd

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Banks, M.L. (2019). The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research. In: Nader, M., Hurd, Y. (eds) Substance Use Disorders. Handbook of Experimental Pharmacology, vol 258. Springer, Cham. https://doi.org/10.1007/164_2019_268

Download citation

Publish with us

Policies and ethics

Search

Navigation